Advertisement
Screener

Canopy Growth Corp (CGC) Deferred Tax Assets, Operating Loss Carryforwards

2.0 / 5 stars · 16/40 Roast Me

Canopy Growth Corp Deferred Tax Assets, Operating Loss Carryforwards

Canopy Growth Corp (CGC) had Deferred Tax Assets, Operating Loss Carryforwards of CAD 1.18 billion as of 2026-03-31, per its 10-K filed 2026-06-15.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-15

  • 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.18B CAD.
  • 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.18B CAD.
  • 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.12B CAD.
  • 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards 1.06B CAD; Deferred Tax Assets, Operating Loss Carryforwards as first filed 1.14B CAD.
Period endDeferred Tax Assets, Operating Loss CarryforwardsDeferred Tax Assets, Operating Loss Carryforwards as first filed
2026-03-311.18B CAD
10-K · filed 2026-06-15
2025-03-311.18B CAD
10-K · filed 2026-06-15
2024-03-311.12B CAD
10-K · filed 2025-05-30
2023-03-311.06B CAD
10-K · filed 2024-05-30
1.14B CAD
10-K · filed 2023-06-22
2022-03-31919.96M CAD
10-K · filed 2023-06-22
917.28M CAD
10-K · filed 2022-05-31
2021-03-31608.00M CAD
10-K · filed 2022-05-31
2020-03-31300.33M CAD
10-K · filed 2021-06-01
2019-03-31108.99M CAD
10-K · filed 2020-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87